FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely oncology, and may be used for treating BcrAbI-positive laukaemia in an imanitib-resistant subject. That is ensured by introducing a therapeutically effective amount of 4-[(2,4-dichlor-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitryl.
EFFECT: use of the given inventions enables ensuring positive cytogenetic and haemotological effects both when treating BcrAbI-positive imanitib-resistant leukaemia, and when observing no resistance-associated mutations.
22 cl, 2 dwg, 2 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF 7-SUBSTITUTED-3-QUINOLINE AND 3-QUINOL-4-ON CARBONITRYLES | 2003 |
|
RU2309149C2 |
METHODS AND MEDICAL APPLICATIONS | 2018 |
|
RU2788174C2 |
METHODS AND MEDICAL APPLICATIONS | 2018 |
|
RU2788163C2 |
METHOD OF OPTIMISING THERAPY OF PHILADELPHIA CHROMOSOME POSITIVE LEUKAEMIA BY Ab1-TYROSINE KINASE INHIBITORS | 2007 |
|
RU2483732C2 |
DEVICE AND METHOD FOR LEUKOCYTE AND CANCER CELL RECOVERY BY FILTRATION | 2012 |
|
RU2578848C2 |
ACRYLANILIDE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN PHARMACOLOGY | 2016 |
|
RU2742372C2 |
PHARMACEUTICAL COMPOSITION, DOSAGE AND METHOD OF TREATMENT PH+ LEUKEMIA | 2017 |
|
RU2664420C1 |
METHOD OF OBTAINING 4-AMINO-3-QUINOLINECARBONITRYLS | 2004 |
|
RU2345069C2 |
ADMINISTRATION OF MIDOSTAURIN FOR TREATING GASTROINTESTINAL STROMAL TUMOURS | 2005 |
|
RU2410098C2 |
METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN CHRONIC MYELOID LEUKEMIA | 2012 |
|
RU2481583C1 |
Authors
Dates
2012-10-20—Published
2008-05-30—Filed